Literature DB >> 7864358

Colorimetric determination of DNase I activity with a DNA-methyl green substrate.

D Sinicropi1, D L Baker, W S Prince, K Shiffer, S Shak.   

Abstract

A simple, high throughput, and precise assay was developed for quantification of deoxyribonuclease I (DNase; IUB 3.1.21.1) activity. The method was adapted from the procedure devised by Kurnick which employs a substrate comprised of highly polymerized native DNA complexed with methyl green. Hydrolysis of the DNA produced unbound methyl green and a decrease in the absorbance of the solution at 620 nm. By adjusting the time and temperature of the reaction, the assay permits quantification of DNase activity over a wide concentration range (0.4 to 8900 ng/ml). Samples and standards were added to the substrate in microtiter plates and were incubated for 1-24 h at 25-37 degrees C to achieve the desired assay range. The DNase activity of the samples was interpolated from a standard curve generated with Pulmozyme recombinant human deoxyribonuclease I (rhDNase). Interassay precision was less than 12% CV and recovery was within 100 +/- 11%. Activity determination by the DNA-methyl green method correlated well with that determined by the widely used "hyperchromicity" method originated by Kunitz, which is based on the increase in absorbance at 260 nm upon hydrolysis of DNA. The DNA-methyl green assay was simpler and more versatile than the hyperchromicity method and was used to characterize the activity of rhDNase and DNase isolated from human urine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7864358     DOI: 10.1006/abio.1994.1502

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  13 in total

1.  Assessment of Deoxyribonuclease Activity in Serum Samples of Patients With Systemic Lupus Erythematosus: Fluorescence-Based Method Versus ELISA.

Authors:  Aleksandra Vancevska; Aleksandra Nikolic; Branka Bonaci-Nikolic; Dusan Skiljevic; Dragica Radojkovic
Journal:  J Clin Lab Anal       Date:  2016-04-18       Impact factor: 2.352

2.  Engineering actin-resistant human DNase I for treatment of cystic fibrosis.

Authors:  J S Ulmer; A Herzka; K J Toy; D L Baker; A H Dodge; D Sinicropi; S Shak; R A Lazarus
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

3.  Mutational analysis of human DNase I at the DNA binding interface: implications for DNA recognition, catalysis, and metal ion dependence.

Authors:  C Q Pan; J S Ulmer; A Herzka; R A Lazarus
Journal:  Protein Sci       Date:  1998-03       Impact factor: 6.725

4.  Pharmacodynamics of recombinant human DNase I in serum.

Authors:  W S Prince; D L Baker; A H Dodge; A E Ahmed; R W Chestnut; D V Sinicropi
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

5.  Inhalable antibiotic delivery using a dry powder co-delivering recombinant deoxyribonuclease and ciprofloxacin for treatment of cystic fibrosis.

Authors:  Yan Yang; Michael D Tsifansky; Chia-Jung Wu; Hae In Yang; Gudrun Schmidt; Yoon Yeo
Journal:  Pharm Res       Date:  2009-10-22       Impact factor: 4.200

6.  Microfabricated engineered particle systems for respiratory drug delivery and other pharmaceutical applications.

Authors:  Andres Garcia; Peter Mack; Stuart Williams; Catherine Fromen; Tammy Shen; Janet Tully; Jonathan Pillai; Philip Kuehl; Mary Napier; Joseph M Desimone; Benjamin W Maynor
Journal:  J Drug Deliv       Date:  2012-02-09

7.  The in vivo expression of actin/salt-resistant hyperactive DNase I inhibits the development of anti-ssDNA and anti-histone autoantibodies in a murine model of systemic lupus erythematosus.

Authors:  Anthony P Manderson; Francesco Carlucci; Peter J Lachmann; Robert A Lazarus; Richard J Festenstein; H Terence Cook; Mark J Walport; Marina Botto
Journal:  Arthritis Res Ther       Date:  2006-04-10       Impact factor: 5.156

8.  Bi-directional SIFT predicts a subset of activating mutations.

Authors:  William Lee; Yan Zhang; Kiran Mukhyala; Robert A Lazarus; Zemin Zhang
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

9.  Secretion of functional human enzymes by Tetrahymena thermophila.

Authors:  Thomas Weide; Lutz Herrmann; Ulrike Bockau; Nadine Niebur; Ingo Aldag; Wouter Laroy; Roland Contreras; Arno Tiedtke; Marcus W W Hartmann
Journal:  BMC Biotechnol       Date:  2006-03-16       Impact factor: 2.563

10.  The bifunctional dihydrofolate reductase thymidylate synthase of Tetrahymena thermophila provides a tool for molecular and biotechnology applications.

Authors:  Lutz Herrmann; Ulrike Bockau; Arno Tiedtke; Marcus W W Hartmann; Thomas Weide
Journal:  BMC Biotechnol       Date:  2006-03-20       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.